Drreddys Laboratories reported INR20.73B in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ani Pharmaceuticals ANIP:US USD 11.9M 7.95M
Aurora Cannabis Inc ACB:CN CAD -63067000 2.66M
Bayer BAYN:GR EUR 2.45B 2.31B
Canopy Growth Corp WEED:CN CAD -95980000 11.78M
Catalent CTLT:US USD 161M 200M
Cipla CIPLA:IN INR 14.08B 1.05B
Corcept Therapeutics CORT:US USD 32.13M 581K
Drreddys Laboratories RDY:US INR 20.73B 1.45B
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
GlaxoSmithKline GSK:LN GBP 1.6B 1.76B
Hikma Pharmaceutical HIK:LN USD 349M 19M
Horizon Pharma HZNP:US USD 287.24M 42.81M
Novartis NOVN:VX USD 4.5B 193M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Prestige Brands PBH:US USD 95.31M 2.68M
Richter Gedeon RICHT:HB HUF 77B 21.49B
Sun Pharmaceuticals SUNP:IN INR 30.07B 1.91B
Teva Pharmaceutical TEVA:IT USD 1.06B 31M